Tuesday, 25 May 2021 06:29 PM MYT
BY JERRY CHOONG
Members of the public wait to receive the AstraZeneca Covid-19 jab at Universiti Malaya, Kuala Lumpur May 5, 2021. Picture by Yusof Mat Isa
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, May 25 The National Pharmaceutical Regulatory Agency (NPRA) today denied that it was slow with the evaluation process for complete Covid-19 vaccine applications as alleged by the Opposition.
The government agency said the regular review period taken to evaluate Covid-19 vaccine applications has been shortened to 120 days now, nearly half the 245 working days it took previously.
Shares of Everest Organics hit a 20 per cent upper circuit limit of Rs 399.50, also its record high on the BSE in Tuesday s session after the company announced a successful development of Posaconazole API (Active Pharmaceutical Ingredient) used for the treatment of Black Fungus. The trading volumes on the counter jumped nearly 10-fold with around 76,000 equity shares having changed hands on the BSE, as against an average sub 8,000 shares that were traded in the past two weeks. There were pending buy orders for 24,195 shares, the exchange data shows. Posaconazole is a triazole antifungal agent indicated for treating mucormycosis, popularly known as Black Fungus, as part of post-Covid complications. The company is in the advanced stage of commercializing the same, Everest Organics said in a press release.
Singapore approves storage of Pfizer-BioNTech COVID-19 vaccine at refrigerator temperatures borneobulletin.com.bn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from borneobulletin.com.bn Daily Mail and Mail on Sunday newspapers.
Amid ongoing global vaccination efforts, the Oxford-AstraZeneca COVID-19 vaccine has stood out for its side effects, with health authorities around the world reporting.
Princess of Kent Reportedly Develops Blood Clots After Getting AstraZeneca s Covid Jab infowars.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infowars.com Daily Mail and Mail on Sunday newspapers.